Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson and Francois Benard
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241500;
Sara Harsini
1BC Cancer
Patrick Martineau
1BC Cancer
Sonia Plaha
2BC Cancer, Canada
Heather Saprunoff
1BC Cancer
Catherine Chen
3Department of Molecular Oncology, BC Cancer Research Institute, BC, Canada
Julia Bishop
1BC Cancer
Scott Tyldesley
1BC Cancer
Don Wilson
1BC Cancer
Francois Benard
4BC Cancer Research Institute
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241500;
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241500;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.